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Highlights 
 Lipid debris accumulation was detected after demyelination with cuprizone 
 Quantification of lipid debris showed gradual increase over time 
 Amount of lipid debris is brain region dependent 
 Detection of lipid debris is capable to reveal early phase of demyelination 
ABSTRACT 
Degradation of myelin sheath is thought to be the cause of neurodegenerative diseases, such as 
multiple sclerosis (MS), but definitive agreement on mechanism of how myelin is lost is currently 
lacking. Autoimmune initiation of MS has been recently questioned by proposing that the immune 
response is a consequence of oligodendrocyte degeneration. To study the process of myelin 
breakdown, we induced demyelination with cuprizone and applied coherent anti-Stokes Raman 
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scattering (CARS) microscopy, a non-destructive label-free method to image lipid structures in living 
tissue. We confirmed earlier results showing a brain region dependent myelin destructive effect of 
cuprizone. In addition, high resolution in situ CARS imaging revealed myelin debris forming lipid 
droplets alongside myelinated axon fibers. Quantification of lipid debris with a custom-made 
software for segmentation and three dimensional reconstruction revealed brain region dependent 
accumulation of lipid drops inversely correlated to the thickness of myelin sheaths. Finally, we 
confirmed that in situ CARS imaging is applicable to living human brain tissue in brain slices derived 
from a patient. Thus, CARS microscopy is potent tool for quantitative monitoring of myelin 
degradation at unprecedented spatiotemporal resolution during oligodendrocyte damage. We think 
that accumulation of lipid drops around degrading myelin might be instrumental in triggering 
subsequent inflammatory processes. 
 
Abbreviations  
BODIPY boron-dipyrromethene 
 
Keywords: Multiple sclerosis; Cuprizone; Demyelination; Lipid debris; CARS imaging 
Introduction 
Multiple sclerosis (MS) is a disease of oligondendrocyte and myelin sheath affecting both the white 
and gray matter with diverse symptoms such as tremor, fatigue and paralysis (Hemmer et al., 2002; 
Trapp and Nave, 2008). In most cases the symptoms occur in a relapsing-remitting manner which 
usually devolves into a persistent progressive state after a decade following onset. MS is caused by 
demyelination and inflammation of axonal tracts. Since myelin acts as an insulator, injury of myelin 
sheaths wrapped around axons of neurons in the CNS it causes malfunction by impairing conduction 
of electric signals (Bando et al., 2008; Hamada and Kole, 2015). Moreover, the loss of myelin cause 
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axonal (Huizinga et al., 2012; Kuhlmann et al., 2002; Lindner et al., 2009) and finally neuronal 
degeneration (Centonze et al., 2010). 
The precise pathological mechanisms involved in MS are subject to considerable debate. Commonly 
MS is defined as an autoimmune disease initiated by an immune system dysregulation leading 
autoreactive T cells to enter the brain, induce microglia and macrophages to attack and erode myelin 
which finally causes the injury of oligondendrocytes (Frohman et al., 2006; Kornek and Lassmann, 
2003; Stadelmann et al., 2011). This theory is corroborated by the fact that current effective 
treatments of MS are based on anti-inflammatory and immunomodulatory agents. Immune 
dysregulation is also supported by the  results of genome-wide association (GWAS) studies showing 
an excessive number of genes influencing T-cell differentiation (Sawcer et al., 2011). However, 
mechanisms of MS initiation are still hypothetical and multiple factors such as gender, viral infection, 
genetic predisposition, environmental and living circumstances were suggested as potential 
contributors (Simpson et al., 2015). An alternative hypothesis for the etiology has been proposed due 
to lack of lymphocytic infiltrates in early lesions (Barnett and Prineas, 2004). It was suggested that 
death of the oligodendrocyte may the primary problem of disease and autoreactivity against due to 
release of myelin debris causing more inflammation and further demyelination (Clarner et al., 2012; 
Stys et al., 2012; Traka et al., 2015). 
Disease models of human demyelination include genetically modified animals, virus and toxin 
induced demyelination and the most frequent rodent model of MS, experimental autoimmune 
encephalomyelitis (EAE) (Merrill, 2009; Ransohoff, 2012). The latter is in agreement with the 
autoimmune disease initiated theory by using an oligodendrocyte specific protein as an antigenic 
component to generate autoreaction against myelin. The present study induces demyelination 
initiated by the loss of olygodendrocytes by using cuprizone as an effective apoptotic agent 
disrupting the energy metabolism of oligodendrocytes through copper depletion (Acs and Kalman, 
2012; Gudi et al., 2014; Kipp et al., 2009; Matsushima and Morell, 2001; Skripuletz et al., 2011) 
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leading to the disintegration of myelin sheath forming processes. Once oligodendrocytes and myelin 
sheaths had been degraded, lipid rich debris must remain. To date, there is no specific data about the 
distribution and amount of myelin debris during the initiation of MS, although it might be a 
significant risk factor in launching inflammatory processes. To preserve chemical composition of 
myelin debris, we used the non-destructive coherent anti-Stokes Raman scattering (CARS) 
microscopy, a label-free imaging method capable of detecting specific molecules in living tissues by 
exciting the characteristic intrinsic vibrational frequency of its molecular bond (Cheng et al., 2002; Fu 
et al., 2008; Haluszka et al., 2015; Hellerer et al., 2007; Saar et al., 2010). We focused femtosecond 
pulsed laser beams combining 796 nm “pump” and 1028 nm “Stokes” beams to acquire excitation of 
vibration resonance of CH2 bonds of lipid molecules. Based on CARS imaging, we quantitatively 
analysed lipid distribution in different areas of acute brain slices of untreated animals, then we 
induced myelin degradation in C57BL/6 mice using cuprizone to induce demyelination. Lipid imaging 
with CARS microscopy on living in vitro brain slice preparations show that mild demyelination causes 
a decrease in the lipid content of white matter leading to the emergence of lipid droplets in the 
extracellular space. Thus, progression in oligodendrocyte death can cause extensive myelin 
degradation coupled to the formation of an abundant mass of phagocyted lipid residue. 
Methods 
Animals, cuprizone treatment and brain slice preparation. 
All procedures were performed according to the National Institutes of Health Guide to the 
Care and Use of Laboratory Animals with the approval of the University of Szeged Ethical 
Committee and Regional Human Investigation Review Board (ref. 75/2014).  
C57BL/6 male mice were used in this study obtained from Charles River (Germany). Animals 
had ad libitum access to standard mouse chow and water. 8 week old mice were treated with 
cuprizone (Sigma-Aldrich) to induce demyelination (Acs and Kalman, 2012; Blakemore, 
1973; Matsushima and Morell, 2001) for up to 5 weeks. 0.2% cuprizone was mixed in the 
AC
CE
PT
ED
 M
AN
US
CR
IPT
5 
 
standard chow of mice. Mice were anaesthetized by inhalation of halothane, and following 
decapitation  250 µm thick coronal slices were prepared from the somatosensory cortex with a 
vibrating blade microtome (Microm HM 650 V) immersed in slicing solution containing (in 
mM): 130 NaCl, 3.5 KCl, 1 NaH2PO4, 24 NaHCO3, 1 CaCl2, 3 MgSO4, 10 D(+)-glucose, 
saturated with 95% O2 and 5% CO2. After cutting procedure slices were incubated at room 
temperature for 1 h in the same solution. The solution used during experiments was identical 
to the slicing solution, except it contained 3 mM CaCl2 and 1.5 mM MgSO4. During image 
acquisition slices were kept at ~35˚C.  
The human tissue obtained from a 67 years old female patient with written informed consent 
prior to surgery. Anesthesia was induced with intravenous midazolam and fentanyl (0.03 
mg/kg, 1–2 mg/kg, respectively). A bolus dose of propofol (1–2 mg/kg) was administered 
intravenously. The patients received 0.5 mg/kg rocuronium to facilitate endotracheal 
intubation. The trachea was intubated and the patient was ventilated with O2/N2O mixture at a 
ratio of 1:2. Anesthesia was maintained with sevoflurane at monitored anesthesia care volume 
of 1.2–1.5. The biopsy taken from the occipital cortex with a deep brain benign tumour. After 
surgical removal tissue blocks were immediately immersed in ice-cold slicing solution. Slice 
preparation was similar as described above, except the thickness of slices were 350 μm.  
Coherent anti-Stokes Raman scattering (CARS) Imaging.  
A prototype of our experimental setup for CARS imaging was detailed earlier (Haluszka et al., 2015). 
Our present system included a FemtoCARS Laser Unit and a FemtoFiber Yb-amplifier (both of R&D 
Ultrafast Lasers Ltd., Hungary), Axio Examiner LSM 7 MP laser scanning 2P microscope (Carl Zeiss, 
Germany) using 40x water immersion objective (W-Plan, Carl Zeiss, Germany) driven by MaiTai 
femtosecond pulsing Ti:sapphire laser (Spectra-Physics, Santa Clara, USA). LSM 7 MP microscope was 
modified for CARS measurements by placing a 650/20 bandpass filter in front of one of the NDDs 
(non-descanned detector). Anti-Stokes frequency was generated by combining 796 nm pump beam 
of Ti-sapphire laser and the 1,028 nm Stokes pulses of the Yb-amplifier using dichroic mirror to excite 
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vibration resonance frequency of CH2 bond, which is present abundantly in saturated fatty acids 
offering chemical selectivity to lipids. 
Time lapse imaging 
Time series Z-stacks CARS images were collected with 60 minutes interval during a 10 hour long 
image acquisition session from white matter tracks with 0.67 µm z steps with 1024x1024 µm 
resolution. Stack images were compressed into single image using a maximum projection algorithm.  
Fluorescence Labeling 
Slices were incubated in a fixating solution which contained 4% paraformaldehyde in 0.1M 
phosphate buffer (PB; pH=7.4) at 4°C for 3 hours. After several washes in 0.1M PB, slices were 
cryoprotected with 10% then 20% sucrose solution in 0.1M PB. Slices were frozen three times in 
liquid nitrogen then embedded in 10% gelatin and further sectioned to 50 µm thick slices. The 
sections were incubated for one hour in 1 µg/ml BODIPY 493/503 (Thermo Fisher Scientific) in tris-
buffered saline (TBS, 0.1M; pH=7.4) at room temperature. The BODIPY 493/503 stock solution (1 
mg/ml) was prepared in DMSO.  After several washes in 0.1M PB, all sections were mounted in 
Vectashield (Vector Laboratories) on slides. BODIPY 493/503 fluorescence was visualized using an 
LSM 880 confocal laser scanning microscope (Carl Zeiss, Germany) with an x40 objective. 
Image analysis 
Intensity measurements in acquired images were analysed in ZEN (Carl Zeiss, Germany) and ImageJ 
(NIH, USA) softwares using images of 20 µm depth from the surface of the brain slice. G ratio was 
calculated as the relation between the inner and outer diameter of the myelinated fiber measured 
on distinct longitudinal fibers parallel with the image plane without the signs of swelling or 
degeneration. Z-stack images were acquired with 1 µm steps. Diameters of fibers were acquired from 
intensity profiles using custom written script in Igor (Wavemetrics, Lake Oswego, USA) by measuring 
at the level of 70% of the amplitude. Intensity profile of fiber was measured perpendicular of the 
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middle plane of the fiber. For detecting and measuring number and volume of lipid debris we used a 
custom written image stack analysis program using C++ language. The program after processing the 
z-stack images by spatial filtering and thresholding, performed 3D particle separation considering 
that particles are distinct and globose shaped. Then volume of separated particles were determined 
based on pixel content. 
Statistical analysis 
All values are given as mean±standard deviation (s.d.) Statistical significance was tested as defined 
for each paradigm; Differences with P<0.05 were considered significant. 
Results 
A custom-made coherent anti-Stokes Raman scattering (CARS) microscope (Fu et al., 2011, 2007; 
Haluszka et al., 2015) equipped with a 40x water immersion objective was used to detect lipid rich 
structures in acute brain slices of 8 week old C57BL/6 mice. By excitation of the CH2 bonds in lipids 
with synchronised laser beams, we aimed to map and characterize lipid distribution in areas of white 
matter and to reveal the structure and dimensions of myelin sheaths. In order to confirm that the 
CARS signal was based on lipids, we performed a histochemical staining of neutral lipids with the dye 
boron-dipyrromethene (BODIPY) on fixed brain slices and detected matching patterns of CARS 
imaging and BODIPY staining in corpus callosum and layer 6 of somatosensory cortex grey matter 
(Figure 1A-C). 
In order to study applicability of the CARS method in clinical investigations, we performed CARS 
imaging on acute slices prepared from a human surgical sample. The biopsy taken from the occipital 
cortex of a 67 years old female patient with a deep brain benign tumour was sliced (350 µm thick) in 
order to perform in vitro imaging. To test long term viability of CARS imaging, time series image Z-
stacks were collected during a 10 hour image acquisition session (see methods). We measured G-
ratios (ratio of the inner diameter to the outer diameter of the myelin) on healthy fibres and found 
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no significant differences during the time course of experiments (P=0.57, t-test, 0.45±0.1, n=28  vs. 
0.46±0.12, n=32 at the start vs. at 600th minute of recording, respectively) (Figure 1D).  
To assess the lipid density of different brain areas, we measured the average pixel intensity of CARS 
images in equally sized square shaped regions (100 µm2). We found differences in average CARS 
signal intensities between different brain areas. Densities of lipids of measured brain areas were 
significantly different (ANOVA: P<0.001) and decreased in the following order: genu of corpus 
callosum (CC) > cerebellum (CB) > forceps minor of corpus callosum (FM) > anterior commissure (CA) 
> subgranular layers of grey matter at primary somatosensory cortex (GM) (Figure 2A, B). When 
comparing measured areas of white matter tracts, a 3-fold difference was found between the highest 
(CC) and lowest (CA) lipid content. Relative to the grey matter in the primary somatosensory cortex, 
areas of white matter showed a 1.2-3.6-fold (CA/GM and CC/GM, respectively) higher in average 
CARS signals.  
Having detected CARS signals in control animals, we proceeded in an experimental model of 
demyelination. We induced lesions of oligodendrocytes using the toxin cuprizone according to an 
induced demyelination model of the mouse brain well characterized in the hippocampus, white 
matter (Acs and Kalman, 2012; Goldberg et al., 2015; Imitola et al., 2011; Komoly, 2005; Koutsoudaki 
et al., 2009; Silvestroff et al., 2012; Skripuletz et al., 2008). C57BL/6 mice were treated for 4-5 weeks 
with 0.2% cuprizone mixed in ground chow with free access to food. We performed CARS imaging in 
cuprizone treated animals and found a significant decrease in averaged pixel intensities of CARS 
signals of the selected areas (Fig 2B) (Mann-Whitney U test: P<0.001). Normalized to control 
measurements treatment decreased CARS signals in a brain region dependent manner to 84.2% - 
34.2%. Maximal reduction of lipid content was found in the corpus callosum where 34.2% of control 
signals were detected following the treatment. The ratio of myelin degradation was correlated with 
control intensities measured in control i.e. areas with higher lipid content in control conditions were 
the most affected by treatment (Figure 2C). 
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We monitored demyelination on the single fiber level with CARS imaging of the corpus callosum by 
measuring the change in G-ratios of longitudinally running axonal fibers without the presence of 
intramyelinic vacuoles or other morphological signs of degeneration. Corroborating results of earlier 
studies (Lindner et al., 2008; Silvestroff et al., 2012), we found a significant decrease in G-ratios after 
cuprizone treatment (0.52 ± 0.11, n=92; t test, p<0.001) relative to control (0.43 ± 0.09, n=115; Figure 
2D).  
An observation based on CARS imaging was the detection of lipid droplets in cuprizone treated 
animals. A surprisingly rich presence of lipid debris (Figures 2A, 3A) along myelinated fibers in the 
form of globose particles with a diameter of 0.3-2 μm was detected in each brain areas imaged from 
all animals. We quantified the amount of lipid particles in two ways: (1) counting the number of 
distinct droplets and (2) measuring 3D volume of droplets as detailed in the methods section. The 
number and overall volume of lipid droplets showed similar tendencies and were different between 
distinct brain areas. In cuprizone treated animals the number (21.38 ± 23.29 particle/104µm3) and 
volume (1.1 ± 1.14 µm3/500 µm3) of lipid droplets was highest in the richly myelinated corpus 
callosum (P<0.001, one sample Wilcoxon signed-rank test) and lowest in the cerebellum (number, 5.8 
± 8.94 particle/104µm3; volume, 0.22 ± 0.43 µm3/500 µm3; Figure 3). The magnitude of lipid debris 
accumulation across various brain regions (CC > FM > CA > GM, excluding CB as discussed below) 
reflected the amounts of intact lipids detected. Moreover, we measured the average pixel intensity 
of CARS images of different brain areas (excluding debris) and compared with the amount of debris in 
the same area. We found significant negative correlation between background lipid content of debris 
free areas and volume of accumulated debris (Figure 3D) (Pearson’s r = -0.75) suggesting the 
transformation of damaged myelin to droplets of lipid debris. 
Discussion 
Mechanistic understanding of the early stages of MS is incomplete and debated. Appearance of the 
first clinical symptoms is usually coupled with the escalation of the disease, thus detection of the 
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initial phase of MS is challenging. We focused on monitoring of myelin sheath breakdown using in 
situ, nondestructive CARS imaging on different brain areas in ex vivo brain slice preparations. We 
analysed baseline lipid content in different brain areas: subgranular layers of the somatosensory 
cortex and white matter tracts of the mouse brain: corpus callosum, forceps minor, anterior 
commisure and cerebellar white matter. As expected, the corpus callosum, being the most heavily 
myelinated area, produced the most intense CARS signals compared to other brain areas, and the 
relatively scarcely myelinated grey matter showed the lowest CARS intensity.  
Oligodendrocytes have a high lipid content (70-85%) (Hildebrand et al., 1993; Quarles et al., 2006), 
therefore apoptosis of these cells and breakdown of the myelin sheath leads to the accumulation of 
lipid debris. Lipid breakdown, however, has not been monitored directly by demyelination studies 
based on immunohistochemical markers of glial proteins (e.g. proteolipid protein, myelin basic 
protein etc.) (Clarner et al., 2012; Gudi et al., 2009; Komoly, 2005; Lindner et al., 2008; Safaiyan et al., 
2016; Skripuletz et al., 2013; Vogel et al., 2013). The method applied here has several advantages 
relative to earlier approaches. Signal detection with CARS microscopy allows direct and quantifiable 
lipid measurements. Moreover, CARS microscopy can be performed in living tissue in situ without 
tissue damage due to the use of multiphoton lasers by tuning our setup for the detection of CH2 
molecular bonds which occur predominantly in lipids. Furthermore, this method is free of potentially 
lipid damaging chemical postprocessing required for immunocytochemical or histochemical studies 
(Sommer and Schachner, 1981). Being a confocal imaging method, three dimensional reconstructions 
and measurements are inherent to CARS imaging. 
Cuprizone treatment applied to initiate selective oligodendrogliopathy in mice is an effective, well 
described and widely used model of MS (Acs and Kalman, 2012; Gudi et al., 2014; Kipp et al., 2009; 
Matsushima and Morell, 2001) working through the disruption of  mitochondrial function followed 
by the decomposition of the myelin sheath. Demyelination was shown to be specific to brain regions 
(Goldberg et al., 2015; Gudi et al., 2009; Komoly, 2005; Koutsoudaki et al., 2009; Maña et al., 2009; 
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Matsushima and Morell, 2001; Silvestroff et al., 2012; Skripuletz et al., 2008) which was recently 
monitored through microglia and astroglia immunohistochemistry (Goldberg et al., 2015). Cuprizone 
acts particularly in the heavily myelinated corpus callosum but also affects other brain areas: 
cerebellar nuclei, optic tracts, hippocampus, putamen, and gray matter areas. The cerebellum 
appears to respond differently to cuprizone treatment (Groebe et al., 2009; Lampron et al., 2015):  
extensive demyelination was observed in deep cerebellar nuclei, but white matter tracts remained 
weakly affected (Groebe et al., 2009). Our experiments show cuprizone induced oligodendropathy 
and myelin destruction using a noninvasive method of detection in situ. We also confirmed 
demyelination by measuring single fiber thickness and calculating G-ratios. Similar to other studies 
(Lindner et al., 2008; Silvestroff et al., 2012) cuprizone caused an increase of the G-ratio indicating 
the reduction of myelin sheath. Elements of the cuprizone model applied here are known to deviate 
from chronic human MS, for example infiltration of  T- and B-cells is inhibited (Emerson et al., 2001; 
Maña et al., 2009). Nevertheless, cuprizone treatment in mice is considered as a useful model to 
study early stages of demyelination revealing an increase in the levels of cytokines and neurotrophic 
factors (Gudi et al., 2009; Matsushima and Morell, 2001; Tanaka et al., 2013) and inducing 
astrogliosis and microglia recruitment (Clarner et al., 2012; Goldberg et al., 2015; Hiremath et al., 
1998; Li et al., 2016; Remington et al., 2007). Activation of microglia is important step in the 
pathogenesis of myelin disorders through the production of intrinsic mediators of cytotoxicity like 
nitric oxide, oxygen radicals, glutamate (Neumann et al., 2008; Peferoen et al., 2014). On the other 
hand, microglias are primarily responsible for scavenging damaged or apoptotic cell parts (Neumann 
et al., 2008; Nimmerjahn et al., 2005).  
Taking advantage of our quantifiable method, spatial distribution of lipid granules were found to be 
clustered with a few scattered single particles. Clustered lipid droplets observed here are reminiscent 
of a phagocited lipid debris (Prineas and Graham, 1981) detected by electron microscopy in samples 
taken at progressed stages of MS (Prineas and Graham, 1981) and similar to findings documented by 
immunocytochemistry on biopsies from human patients (Huizinga et al., 2012). Moreover, the so 
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called “foamy” macrophages (Peferoen et al., 2014; Smith, 1999) containing neutral lipid droplets, 
suggested as residuals of lipid phagocytosis, can be readily detected in autopsies of human MS 
patients (Boven et al., 2006; Vogel et al., 2013).  More recently, Safaiyan and co-workers (Safaiyan et 
al., 2016) showed that lipid degraded by cuprizone treatment turns up in microglia and accumulates 
over time. Clearance of myelin debris following the loss of oligodendrocytes is a multifaceted process 
working at variable timescales (Vargas and Barres, 2007). Proteins are degraded within days e.g. 
myelin–oligodendrocyte glycoproteins (MOG) and myelin-associated glycoproteins (MAG) are 
degraded in 3 days, other proteins such as myelin basic protein (MBP) and proteolipid protein (PLP) 
takes approximately 10 days to eliminate (Brück et al., 1995). Lipid degradation, however, takes 
much longer and needs presumably more than a year (Adams, 1989), e.g. lipid granules were 
detected after 9 months  after cuprizone induced demyelination (Safaiyan et al., 2016).  
Mechanistically, MS is thought to be initiated by autoimmune elements with a major role of CD4+ and 
CD8+ T cells and additional contribution of other immune cells and pro-inflammatory molecules like 
cytokines (Noseworthy et al., 2000). It is yet to be decided whether the traditional immune-mediated 
hypothesis or a more recently suggested alternative, the so called inside-out model explains the 
onset of MS (Stys et al., 2012). The inside-out model unfolded from studies on autopsies of still 
myelinated tissue regions of MS patients with apoptotic loss of oligodendrocytes showing microglial 
activation but without signs of T and B cell infiltration (Barnett and Prineas, 2004; Barnett and 
Sutton, 2006). The pathogenesis of MS has different variants and complex etiology compromising 
different stages (Van Der Valk and De Groot, 2000). Cuprizone is an effective tool to study the early 
stage of MS and, in particular the process of oligodendrocyte lesion and formation and elimination of 
myelin debris.  Trigger event(s) of MS are not clear. According to the inside-out hypothesis, direct 
oligodendrogliopathy induced by a causative agent is feasible. A recently identified candidate 
compound in such a process is the toxin of Clostridium perfrigens type B known to cause specific 
oligodendrocyte death (Linden et al., 2015; Rumah et al., 2013). Alternatively, scavenger 
macrophages entering the brain were hypothesized to be directed against surface components and 
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cause myelin destruction (Smith, 1999; van der Valk and Amor, 2009). It is speculated that blood 
derived macrophage or microglia might react against myelin without a known mechanism initiating 
the process. Our results show the accumulation of lipid droplets which can turn into a subsequent 
agglomeration at later stages. Recent observations demonstrating the lack of immune response 
against slowly degrading myelin during the first 40 weeks of oligodendrocyte loss and demyelination  
(Traka et al., 2015) suggest that the onset of oligodendrocyte death is likely to be independent of the 
complement system. Clustering of lipid droplets is consistent with the involvement of macrophages 
and generation of inflammation (Wang et al., 2015). Inflammation in the CNS can be induced by 
sulfatide, a major component of myelin sheath (Jeon et al., 2008) and lipid laden macrophages can 
generate a chronic inflammatory state in the spinal cord (Wang et al., 2015). Moreover, recent 
studies showed that injection of homogenized lipid debris into the brain generates enormous 
microglia recruitment and triggers inflammatory responses (Clarner et al., 2012; Sun et al., 2010). 
When lipids are released from dying myelin sheaths, they might exacerbate the condition by 
inhibiting CNS remyelination (Kotter, 2006; Lampron et al., 2015). Thus, our measurements suggest 
that oligodendrocyte death in the cuprizone model of MS may followed by the gradual accumulation 
of sporadic lipid droplets without rapid degradation of their lipid content which eventually can lead 
to lipid droplet agglomeration in macrophages and onset of inflammation.   
Legends to Figures 
Figure 1. CARS intensity reflects lipid rich structures in cortical slice of mouse and human. (A) 
Diagram shows control coronal brain section. Red and blue outlines indicate imaged areas shown in A 
and B, respectively. (B) Top: Representative CARS image of corpus callosum from mouse brain slice. 
Bottom: Same sample histochemical staining with BODIPY. (C) Left: Representative CARS image of 
corpus callosum from mouse brain slice. Right: Same sample stained with BODIPY. Note the similar 
fiber patterns on the left side of images. (D) Representative CARS images of white matter of cortical 
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slice from biopsy of human patient before (left) and after (right) long term in vitro recording session. 
Scalebars, 20 μm. 
Figure 2. Detection of demyelination with CARS in cuprizone treated animals. (A) Representative 
CARS images of control (left) and 0.2% cuprizone (right) treated sample from corpus callosum. (B) 
Quantification of myelin density by measuring averaged total CARS intensity of selected areas of 
brain slices from control (left) and 0.2% cuprizone (right) treated mice. (C) Scatter plots showing the 
average pixel intensity values comparing with loss of lipid during different concentrations of 
treatments. Cerebellar data point (hollow symbol) was excluded from line fit (see discussion). (D) 
Cuprizone treatment induce change of G-ratio of myelin sheath. Images are representative examples 
of images of myelin sheaths in control (left) and 0.2% (right) cuprizone treatment. CARS pixel 
intensity were measured along profiles indicated with white lines perpendicular to fibers. Scalebars, 
(A) 20 μm; (D) 5 μm. Mann-Whitney U test: ***p<0.001 
Figure 3. Quantification of accumulated myelin debris in white matter structures. (A) 
Representative photos showing CARS signal images brain slices acquired from control (left) and 0.2% 
cuprizone treated (right) animals from brain areas indicated on the top drawings. Red arrows indicate 
solitary and conglomerates of myelin debris. (B) Representative sample of 3D volume reconstruction 
of image stack (71x71x10 μm) originate from a cuprizone treated animal. (C) Quantification of 
number and volume of myelin debris in different brain regions after 0.2% cuprizone treatment. (D) 
Scattergram shows negative correlation of measured lipid debris number and measured CARS 
intensity in corpus callosum cuprizone treated tissue. Scalebars, 10 μm.CA anterior commissure  
CARS coherent anti-Stokes Raman scattering 
CB cerebellum  
CC corpus callosum  
CNS central nervous sytem 
AC
CE
PT
ED
 M
AN
US
CR
IPT
15 
 
FM forceps minor of corpus callosum  
GM grey matter  
MAG myelin-associated glycoproteins 
MOG myelin–oligodendrocyte glycoproteins  
EAE experimental autoimmune encephalomyelitis 
GWAS genome-wide association studies 
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